Abstract
Nanotechnology has revolutionized the field of drug delivery, offering targeted, efficient, and controlled release of therapeutic agents. By employing nanocarriers such as liposomes, dendrimers, and nanoparticles, drugs can be delivered directly to diseased cells, reducing side effects and enhancing bioavailability. This paper explores the mechanisms, materials, and clinical advancements in nanotechnology-based drug delivery systems. It emphasizes how nanoscale materials can overcome biological barriers, enhance pharmacokinetics, and support personalized medicine approaches. The study also discusses regulatory challenges and future prospects in this evolving field.
References
Ahmad, N. R. (2025). Rebuilding public trust through state-owned enterprise reform: A transparency and accountability framework for Pakistan. Punjab Sahulat Bazaars Authority. https://doi.org/10.52152/6q2p9250
Ahmad, N. R. (2025). Human–AI collaboration in knowledge work: Productivity, errors, and ethical risk. https://doi.org/10.52152/6q2p9250

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Austra & Lian Journal of Basic Sciences